Geratherm Medical AG

Earnings Release • Feb 18, 2010

News Details

Ad-hoc | 18 February 2010 11:58

Geratherm Medical AG: Geratherm Medical’s Provisional, Uncertified 2009

Geratherm Medical AG / Preliminary Results

18.02.2010 11:58

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

DGAP Current Report: Geratherm Medical's Provisional, Uncertified 2009
Financial Statement

Notice pursuant to §15 WpHG (Wertpapierhandelsgesetz, German Securities
Trading Law) by DGAP, a subsidiary of Equity Story AG. The issuer is solely
responsible for the contents of this notice.

Geratherm Medical: Provisional, Uncertified 2009 Financial Statement

• Sales revenue: EUR 14.4 million +42.7%

• EBITDA: EUR 2.6 million +193%

• EBIT: EUR 2.2 million +280%

• EAT: EUR 2.7 million

• EPS: EUR 0.59

• Proposed dividend: EUR 0.40 per share

Geschwenda, February 18, 2010. Geratherm Medical was able to increase its
sales revenue significantly in the 2009 financial year, gaining 42.7%.
Gross profits likewise increased by 42.5% to EUR 8.7 million. Earnings
before interest and taxes more than tripled thanks to an EBIT margin of
15.7%. Combined with a positive financial result of EUR 560,000, this
brings the 2009 financial year's earnings after taxes (EAT) to EUR 2.7
million, or 59 euro cents per share for the shareholders of the parent
company. The income and expenses reported directly in the equity capital in
keeping with the reinstatement of original values amounted to EUR 2.4
million, so that the consolidated earnings for the 2009 financial year were
EUR 5.1 million. The proposed dividend is 40 euro cents per share. As in
previous years, the dividend will be paid out tax-free from the
shareholders' contribution account pursuant to §27 KStG
(Körperschaftssteuergesetz, German Corporation Tax Law).

The outlook for 2010: Barring changes in the prevailing conditions, the
growth in the company and its earnings will very probably continue in 2010.

The publication of definitive figures for the 2009 financial year is
planned for April 15, 2010.

Short company profile

Geratherm Medical is an internationally operating medical products
enterprise with the business areas 'Temperature Management', 'Cardio' and
'Respiratory'.

Our company's roots are in temperature measurement in the medical sphere.
In this business area we offer a broad spectrum of products, most of which
have unique selling points. We supply our customers/patients with
high-quality products ranging from thermometers to complex warming systems
for use in the operating theatre and by emergency rescue services. In the
Cardio business area we concentrate on the development of products for the
detection of atrial fibrillation as a measure to prevent strokes. The
Respiratory segment develops and markets products for the assessment of
pulmonary function.

In all three business areas, Geratherm has patent-protected basic
technologies at its disposal. We regard ourselves as a research-based
medical products company with a clear focus on medical diagnostic devices
that generate vital data.

Geratherm shares have been listed in the Prime Standard segment of the
Frankfurt Stock Exchange since the year 2000. Geratherm Medical continues
to be represented in the German Entrepreneurial Index and in the German
Health-Care Index.

Geratherm Medical AG, Investor Relations

Fahrenheitstraße 1, 98716 Geschwenda

Tel. +49 (0)36205/98 111, E-Mail: info@geratherm.com www.geratherm.com

Emittent: Geratherm Medical AG, Fahrenheitstraße 1, 98716 Geschwenda
Deutschland

Tel. 036205/98 111 Fax: 036205/98 115

ISIN : DE 000 549 562 6

WKN : 549 562

Börsen : Frankfurter Wertpapierbörse /Geregelter Markt/Prime Standard

Börse: Freiverkehr in Berlin-Bremen, Düsseldorf, Hamburg, München,
Stuttgart

• Ende der Mitteilung -

18.02.2010 Ad hoc announcement, Financial News and Media Release distributed by DGAP.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language: English
Company: Geratherm Medical AG
Fahrenheitstraße 1
98716 Geschwenda
Deutschland
Phone: +49 (0)36205 98-0
Fax: +49 (0)36205 98-1 15
E-mail: info@geratherm.com
Internet: www.geratherm.com
ISIN: DE0005495626
WKN: 549562
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, München, Hamburg, Stuttgart

End of News DGAP News-Service

---